| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/27/2009 | CA2186747C Interleukin-15 |
| 01/27/2009 | CA2135644C Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 01/27/2009 | CA2132414C Nucleic acid fragments and methods for increasing the lysine and threonine content of the seeds of plants |
| 01/27/2009 | CA2045869C Fusion proteins with immunoglobulin portions, the preparation and use thereof |
| 01/22/2009 | WO2009012428A2 Differentiation of human embryonic stem cells |
| 01/22/2009 | WO2009012357A2 Methods to identify and enrich for populations of ovarian cancer stem cells and somatic ovarian stem cells and uses thereof |
| 01/22/2009 | WO2009012140A2 Drug selection for lung cancer therapy using antibody-based arrays |
| 01/22/2009 | WO2009011725A1 Method for transforming soybean (glycine max) |
| 01/22/2009 | WO2009011663A1 Method for differentiating embryonic stem cells into cells expressing aqp-1 |
| 01/22/2009 | WO2009011546A2 Method for promoting the self-renewal of adult stem cells using mesenchymal stromal cells |
| 01/22/2009 | WO2009011413A1 Production and use of epitope-tagged hepatitis c virus particle |
| 01/22/2009 | WO2009011258A1 Method for maintaining foreign gene in cell stably |
| 01/22/2009 | WO2009011139A1 Method for isolation of cell, serum-free culture medium for cell, and method for culture of cell |
| 01/22/2009 | WO2009011125A1 Novel isomaltooligosaccharide synthase |
| 01/22/2009 | WO2009010976A2 Compositions and methods for purifying and crystallizing molecules of interest |
| 01/22/2009 | WO2009010885A2 Use of cd200 as a mesenchymal stem cells marker |
| 01/22/2009 | WO2009010841A2 Culture for expanding stem cells ex-vivo |
| 01/22/2009 | WO2009010661A2 Reactor for the implementation of a bone tissue culture method |
| 01/22/2009 | WO2009010652A1 Method for proliferation of cells on polyelectrolyte multilayer films and use thereof, particularly for the preparation of cellular biomaterials |
| 01/22/2009 | WO2009010392A1 Agents containing proteases from stenotrophomonas maltophilia |
| 01/22/2009 | WO2009010232A1 Biomaterial based on a hydrophilic polymer carrier |
| 01/22/2009 | WO2009010194A1 Polymer scaffold material for cultivating cells |
| 01/22/2009 | WO2009009906A1 Isoflavonoid production in plants |
| 01/22/2009 | WO2009009883A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2009009882A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2009009881A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2008108794A3 Controlling dendritic cell maturation state in the lymphoid tissue equivalent of an artificial immune system |
| 01/22/2009 | WO2008075378A3 Xeno-free culture conditions for human embryonic stem cells and methods thereof |
| 01/22/2009 | WO2007070538A9 Anti-mn antibodies and methods of using same |
| 01/22/2009 | US20090025107 Polypeptides Having Organophosphorus Hydrolase Activity and Polynucleotides Encoding Same |
| 01/22/2009 | US20090025106 C-terminally truncated interferon |
| 01/22/2009 | US20090025102 Glutamate receptor associated genes and proteins for enhancing nitrogen utilization efficiency in crop plants |
| 01/22/2009 | US20090025100 DWF12 and Mutants Thereof |
| 01/22/2009 | US20090025097 Shrna and sirna and mirna expression in a living organism under control of a codon-optimized repressor gene |
| 01/22/2009 | US20090025096 P4has as modifiers of the igfr pathway and methods of use |
| 01/22/2009 | US20090023773 Compositions and methods for modulating gated ion channels |
| 01/22/2009 | US20090023739 Capase inhibitors and uses thereof |
| 01/22/2009 | US20090023671 Rnai Agents for Maintenance of Stem Cells |
| 01/22/2009 | US20090023666 Modulators of Hypoxia Inducible Factor-1 and Related Uses |
| 01/22/2009 | US20090023659 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 01/22/2009 | US20090023653 Method of using broad-spectrum delta-endotoxins |
| 01/22/2009 | US20090023649 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors |
| 01/22/2009 | US20090023648 Methods for Treating Body Tissue |
| 01/22/2009 | US20090023645 AIB1, a novel steroid receptor co-activator |
| 01/22/2009 | US20090023635 Factor VII or VIIa - Like Molecules |
| 01/22/2009 | US20090023630 Methods and Means for Use in Diagnostics and Treatment of Diabetes |
| 01/22/2009 | US20090023224 Vascular endothelial growth factor 2 |
| 01/22/2009 | US20090023214 thawing cryopreserved plant cells and incubating thawed cells with a recovery agent selected from canine IL-4 and human gamma interferon |
| 01/22/2009 | US20090023213 Method to increase the rate of transgenic embryo formation after inoculation of immature cotyledons with agrobacterium |
| 01/22/2009 | US20090023212 Method for transforming soybean (Glycine max) |
| 01/22/2009 | US20090023211 Blood platelet lysate and method of producing the same |
| 01/22/2009 | US20090023210 B-cyclodextrin derivatives and their use against anthrax lethal toxin |
| 01/22/2009 | US20090023209 Solution for the indefinite maintenance of nucleic acids in the cell of origin thereof |
| 01/22/2009 | US20090023208 Cultivation of Primate Embryonic Cells |
| 01/22/2009 | US20090023207 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
| 01/22/2009 | US20090023206 Microinjection apparatus and method of injecting fluid |
| 01/22/2009 | US20090023205 Method for the separation of living cells |
| 01/22/2009 | US20090023196 Stocks of replication-deficient adenovirus |
| 01/22/2009 | US20090023188 Using Pasteurella; genetic engineering; purified nucleic acid segments |
| 01/22/2009 | US20090023185 Avidin Mutants |
| 01/22/2009 | US20090023184 Novel Tachykinin Peptides, Precursor Peptides Thereof And Genes Encoding The Same |
| 01/22/2009 | US20090023180 Reduction of Shading in Microalgae |
| 01/22/2009 | US20090023162 Method for the identification of atypical p-anca |
| 01/22/2009 | US20090023159 Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody |
| 01/22/2009 | US20090023152 Transcription factor MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substances |
| 01/22/2009 | US20090022817 Methods of modifying myocardial infarction expansion |
| 01/22/2009 | US20090022776 Composition and method for treatment and prevention of restenosis |
| 01/22/2009 | US20090022768 Continuous flow chamber device for separation, concentration, and/or purification of cells |
| 01/22/2009 | US20090022762 Polyvalent influenza virus-like particle (VLP) compositions |
| 01/22/2009 | US20090022759 Adenovirus vector and method to manipulate the adenovirus genome |
| 01/22/2009 | US20090022753 Surface proteins of streptococcus pyogenes |
| 01/22/2009 | US20090022748 Unique associated Kaposi's sarcoma virus sequences and uses thereof |
| 01/22/2009 | US20090022747 B7-h3 and b7-h4, novel immunoregulatory molecules |
| 01/22/2009 | US20090022746 Complexes for transferring nucleic acids into cells |
| 01/22/2009 | US20090022738 Multispecific deimmunized CD3-binders |
| 01/22/2009 | US20090022737 Aldos as modifiers of the igf pathway and methods of use |
| 01/22/2009 | US20090022736 Monoclonal Antibodies That Specifically Bind To And Neutralize Bacillus Anthracis Toxin, Compositions, And Methods Of Use |
| 01/22/2009 | US20090022735 Receptor Binding Polypeptides |
| 01/22/2009 | US20090022729 Methods and compositions for treating cardiac dysfunctions |
| 01/22/2009 | US20090022725 antagonist antibody that blocks binding of IL-17; degenerative cartilaginous disorders and other inflammatory diseases |
| 01/22/2009 | US20090022724 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 01/22/2009 | US20090022723 Anti-il-tif antibodies and methods of using in inflammation |
| 01/22/2009 | US20090022721 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 01/22/2009 | US20090022712 Compositions and Methods for Inhibiting Leukocyte Function |
| 01/22/2009 | US20090022710 Nuclear factor of activated t cells receptor |
| 01/22/2009 | US20090022705 Chloroplasts engineered to express pharmaceutical proteins in edible plants |
| 01/22/2009 | US20090022699 Method Of Genotypically Modifying Cells By Administration Of RNA |
| 01/22/2009 | US20090022698 Composition For Treatment Of Articular Cartilage Damage |
| 01/22/2009 | US20090022697 System for the Implantation of Cardiac Staminal Cells with the "Ciuro? Method" |
| 01/22/2009 | US20090022696 Methods for immortalizing cells |
| 01/22/2009 | US20090022695 Method for expansion of tumour-reactive t-lymphocytes for immunotherapy of patients with specific cancer types |
| 01/22/2009 | US20090022694 Sirt1 inhibition |
| 01/22/2009 | US20090022693 Method forisolating stem cells from cryopreserved dental tissue |
| 01/22/2009 | US20090022663 Antibodies and related molecules that bind to 161p2f10b proteins |
| 01/22/2009 | US20090022662 Cancerous disease modifying antibodies |
| 01/22/2009 | US20090022661 Cancerous disease modifying antibodies |
| 01/22/2009 | US20090022660 Monoclonal antibodies comprising cytotoxic agent capable of inducing antibody dependent cellular cytotoxicity directed towards tumorus tissues |
| 01/22/2009 | US20090022659 Antibodies to TNF alpha and use thereof |
| 01/22/2009 | CA2696437A1 Production and use of epitope-tagged hepatitis c virus particle |
| 01/22/2009 | CA2693420A1 Culture for expanding stem cells ex-vivo |